Remecure ApS: Financial statements 2024
CVR: 40259724
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Remecure ApS (CVR 40259724) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -11,891 and a net result of DKK -17,659 compared with DKK 238,485 the year before. Equity in the 2024 report amounted to DKK 229,371. The solvency ratio was 23.2%.
- Gross Profit
- DKK -11,891
- Profit/Loss
- DKK -17,659
- Equity
- DKK 229,371
- Total Assets
- DKK 988,288
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -12 t. | -18 t. | 229 t. | 0 |
| 2023 | - | 298 t. | 238 t. | 247 t. | 0 |
| 2022 | - | -31 t. | -39 t. | 9 t. | 0 |
| 2021 | - | 20 t. | 17 t. | 47 t. | 0 |
| 2020 | - | -295 | -554 | -10 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Remecure ApS has published its annual report for 2023. Gross profit came to DKK 298,470, and the net result was DKK 238,485.
About Remecure ApS
Remecure ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Stephanie Cecilia Arnfeldt Castella and Mohamed MAMDOUH Takach. The company is owned by Stephanie Cecilia Arnfeldt Castella and Mohamed MAMDOUH Takach. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 8,950 and a net result of DKK 5,453 compared with DKK -17,659 the year before. Equity in the 2025 report amounted to DKK 234,891.